tiprankstipranks
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY
US Market
SNPHY
Santen Pharmaceutical Co
RESEARCH TOOLSreports
Want to see SNPHY full AI Analyst Report?

Santen Pharmaceutical Co (SNPHY) Financial Statements

5 Followers

Santen Pharmaceutical Co Financial Overview

Santen Pharmaceutical Co's market cap is currently $3.85B. The company's EPS TTM is $116.58; its P/E ratio is 14.59; and it has a dividend yield of 2.02%. Santen Pharmaceutical Co is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 300.00B¥ 309.21B¥ 301.96B¥ 279.04B¥ 266.26B
Gross Profit¥ 171.03B¥ 170.68B¥ 178.71B¥ 166.09B¥ 156.59B
Operating Income¥ 46.88B¥ 47.94B¥ 38.54B¥ -3.09B¥ 35.89B
EBITDA¥ 59.01B¥ 67.41B¥ 50.72B¥ 12.95B¥ 52.93B
Net Income¥ 36.26B¥ 39.62B¥ 26.64B¥ -14.95B¥ 27.22B
Balance Sheet
Cash & Short-Term Investments¥ 93.99B¥ 81.23B¥ 94.96B¥ 58.68B¥ 84.31B
Total Assets¥ 409.28B¥ 424.87B¥ 435.70B¥ 421.18B¥ 459.98B
Total Debt¥ 34.23B¥ 0.00¥ 35.16B¥ 36.21B¥ 32.93B
Net Debt¥ -93.00B¥ -81.23B¥ -59.42B¥ -21.70B¥ -50.08B
Total Liabilities¥ 124.10B¥ 127.57B¥ 130.33B¥ 127.88B¥ 123.13B
Stockholders' Equity¥ 286.24B¥ 298.28B¥ 306.06B¥ 293.98B¥ 337.49B
Cash Flow
Free Cash Flow¥ 54.27B¥ 38.87B¥ 61.96B¥ 12.56B¥ 10.20B
Operating Cash Flow¥ 60.93B¥ 46.12B¥ 72.65B¥ 37.15B¥ 46.04B
Investing Cash Flow¥ -8.22B¥ -13.76B¥ -6.14B¥ -26.78B¥ -35.17B
Financing Cash Flow¥ -53.31B¥ -52.32B¥ -34.03B¥ -37.22B¥ 5.56B
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History

Income Statement >

Santen Pharmaceutical Co Debt to Assets

Balance Sheet >

Santen Pharmaceutical Co Cash Flow

Cash Flow >

Santen Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >